Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy   |   
enzyme (lysozyme)

 
Enzymes
  Enzyme classes:
  EC 1: Oxidoreductases
  EC 2: Transferases
    EC 2.1
    EC 2.2
    EC 2.3
    EC 2.4
    EC 2.5
    EC 2.6
    EC 2.7
      EC 2.7.1
      EC 2.7.2
      EC 2.7.3
      EC 2.7.4
      EC 2.7.5
      EC 2.7.6
      EC 2.7.7
      EC 2.7.8
      EC 2.7.9
      EC 2.7.10
      EC 2.7.11
        EC 2.7.11.1
        EC 2.7.11.2
        EC 2.7.11.3
        EC 2.7.11.4
        EC 2.7.11.6
        EC 2.7.11.7
        EC 2.7.11.8
        EC 2.7.11.9
        EC 2.7.11.10
        EC 2.7.11.11
        EC 2.7.11.12
        EC 2.7.11.13
        EC 2.7.11.14
        EC 2.7.11.15
        EC 2.7.11.16
        EC 2.7.11.17
        EC 2.7.11.18
        EC 2.7.11.19
        EC 2.7.11.20
        EC 2.7.11.21
        EC 2.7.11.22
        EC 2.7.11.23
        EC 2.7.11.24
        EC 2.7.11.25
        EC 2.7.11.26
        EC 2.7.11.27
        EC 2.7.11.28
        EC 2.7.11.29
        EC 2.7.11.30
        EC 2.7.11.31
      EC 2.7.12
      EC 2.7.13
      EC 2.7.14
    EC 2.8
    EC 2.9
  EC 3: Hydrolases
  EC 4: Lyases
  EC 5: Isomerases
  EC 6: Ligases
  General information:
  Catalytic mechanism
  Enzyme kinetics
  Inhibitors
  Enzymes in industry

EC 2.7.11.26 - ATP:[ tau- protein] O- phosphotransferase ( tau- protein kinase)



3D structures of EC 2.7.11.26 - tau-protein kinase in Protein Data Bank

updated: 29 May 2015, 1:12

In total: 68 PDB structures of EC 2.7.11.26 - tau-protein kinase:
  1. 3l1s: 3-aryl-4-(arylhydrazono)-1h-pyrazol-5-ones: Highly Ligand Efficient and Potent Inhibitors of Gsk3
  2. 3i4b: Crystal Structure of GSK3B in Complex with a Pyrimidylpyrrole Inhibitor
  3. 3gb2: GSK3BETA Inhibitor Complex
  4. 3f88: Glycogen Synthase Kinase 3beta Inhibitor Complex
  5. 3f7z: X-ray Co-crystal Structure of Glycogen Synthase Kinase 3beta in Complex with an Inhibitor
  6. 3du8: Crystal Structure of Gsk-3 Beta in Complex with Nms-869553a
  7. 3cqw: Crystal Structure of Akt-1 Complexed with Substrate Peptide and Inhibitor
  8. 3cqu: Crystal Structure of Akt-1 Complexed with Substrate Peptide and Inhibitor
  9. 2xh5: Structure of 4-(4-tert-butylbenzyl)-1-(7h-pyrrolo(2,3-d) Pyrimidin-4-yl)piperidin-4-amine Bound to Pkb
  10. 2x39: Structure of 4-amino-n-(4-chlorobenzyl)-1-(7h-pyrrolo(2,3-d) Pyrimidin-4-yl)piperidine-4-carboxamide Bound to Pkb
  11. 2uw9: Structure of Pkb-beta (akt2) Complexed with 4-(4-chloro- Phenyl)-4-(4-(1h-pyrazol-4-yl)-phenyl)-piperidine
  12. 2ow3: Glycogen Synthase Kinase-3 Beta in Complex with Bis- (indole)maleimide Pyridinophane Inhibitor
  13. 2o5k: Crystal Structure of GSK3BETA in Complex with a Benzoimidazol Inhibitor
  14. 2jdo: Structure of Pkb-beta (akt2) Complexed with Isoquinoline-5- Sulfonic Acid (2-(2-(4-chlorobenzyloxy) Ethylamino)ethyl) Amide
  15. 2jdr: Structure of Pkb-beta (akt2) Complexed with The Inhibitor A- 443654
  16. 2jld: Extremely Tight Binding of Ruthenium Complex to Glycogen Synthase Kinase 3
  17. 3m1s: Structure of Ruthenium Half-sandwich Complex Bound to Glycogen Synthase Kinase 3
  18. 3pup: Structure of Glycogen Synthase Kinase 3 Beta (GSK3B) in Complex with a Ruthenium Octasporine Ligand (os1)
  19. 3q3b: 6-amino-4-(pyrimidin-4-yl)pyridones: Novel Glycogen Synthase Kinase-3 Inhibitors
  20. 3zrk: Identification of 2-(4-pyridyl)thienopyridinones as Gsk-3beta Inhibitors
  21. 3zrl: Identification of 2-(4-pyridyl)thienopyridinones as Gsk-3beta Inhibitors
  22. 3zrm: Identification of 2-(4-pyridyl)thienopyridinones as Gsk- 3beta Inhibitors
  23. 3sd0: Identification of a Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity in Clock Mutant Mice
  24. 4dit: Crystal Structure of GSK3BETA in Complex with a Imidazolopyridine Inhibitor
  25. 4afj: 5-aryl-4-carboxamide-1,3-oxazoles: Potent and Selective Gsk-3 Inhibitors
  26. 4acc: GSK3B in Complex with Inhibitor
  27. 4acd: GSK3B in Complex with Inhibitor
  28. 4acg: GSK3B in Complex with Inhibitor
  29. 4ach: GSK3B in Complex with Inhibitor
  30. 4ekk: Akt1 with Amp-pnp
  31. 3say: Crystal Structure of Human Glycogen Synthase Kinase 3 Beta (GSK3B) in Complex with Inhibitor 142
  32. 4eai: Co-crystal Structure of an Ampk Core with Amp
  33. 4eaj: Co-crystal of Ampk Core with Amp Soaked with Atp
  34. 4eak: Co-crystal Structure of an Ampk Core with Atp
  35. 4eal: Co-crystal of Ampk Core with Atp Soaked with Amp
  36. 4hgt: Crystal Structure of CK1D with Compound 13
  37. 4hnf: Crystal Structure of CK1D in Complex with Pf4800567
  38. 3zdi: Glycogen Synthase Kinase 3 Beta Complexed with Axin Peptide and Inhibitor 7d
  39. 4b7t: Glycogen Synthase Kinase 3 Beta Complexed with Axin Peptide and Leucettine L4
  40. 4j1r: Crystal Structure of GSK3B in Complex with Inhibitor 15r
  41. 4j71: Crystal Structure of GSK3B in Complex with Inhibitor 1r
  42. 4iq6: Gsk-3beta with Inhibitor 6-chloro-n-cyclohexyl-4-(1h-pyrrolo[2,3- B]pyridin-3-yl)pyridin-2-amine
  43. 4jjr: A P21 Crystal Form of Mammalian Casein Kinase 1d with a Novel Dimer Interface.
  44. 4f2l: Structure of a Regulatory Domain of Ampk
  45. 4btj: Ttbk1 in Complex with Atp
  46. 4btk: Ttbk1 in Complex with Inhibitor
  47. 4btm: Ttbk1 in Complex with Inhibitor
  48. 4kb8: CK1D in Complex with 1-{4-[3-(4-fluorophenyl)-1-methyl-1h-pyrazol-4- Yl]pyridin-2-yl}-n-methylmethanamine Ligand
  49. 4kba: CK1D in Complex with 9-[3-(4-fluorophenyl)-1-methyl-1h-pyrazol-4-yl]- 2,3,4,5-tetrahydropyrido[2,3-f][1,4]oxazepine Inhibitor
  50. 4kbc: CK1D in Complex with {4-[3-(4-fluorophenyl)-1h-pyrazol-4-yl]pyridin-2- Yl}methanol Inhibitor
  51. 4kbk: CK1D in Complex with (3s)-3-{4-[3-(4-fluorophenyl)-1-methyl-1h- Pyrazol-4-yl]pyridin-2-yl}morpholine Inhibitor
  52. 4nm0: Crystal Structure of Peptide Inhibitor-free Gsk-3/axin Complex
  53. 4nm3: Crystal Structure of Gsk-3/axin Complex Bound to Phosphorylated N- Terminal Auto-inhibitory Ps9 Peptide
  54. 4nm5: Crystal Structure of Gsk-3/axin Complex Bound to Phosphorylated Wnt Receptor Lrp6 C-motif
  55. 4nm7: Crystal Structure of Gsk-3/axin Complex Bound to Phosphorylated Wnt Receptor Lrp6 E-motif
  56. 4nu1: Crystal Structure of a Transition State Mimic of The Gsk-3/axin Complex Bound to Phosphorylated N-terminal Auto-inhibitory Ps9 Peptide
  57. 4qfg: Structure of Ampk in Complex with Staurosporine Inhibitor and in The Absence of a Synthetic Activator
  58. 4qfr: Structure of Ampk in Complex with Cl-a769662 Activator and Staurosporine Inhibitor
  59. 4qfs: Structure of Ampk in Complex with BR2-A769662CORE Activator and Staurosporine Inhibitor
  60. 4tw9: Difluoro-dioxolo-benzoimidazol-benzamides as Potent Inhibitors of CK1DELTA and Epsilon with Nanomolar Inhibitory Activity on Cancer Cell Proliferation
  61. 4twc: 2-benzamido-n-(1h-benzo[d]imidazol-2-yl)thiazole-4- Carboxamide Derivatives as Potent Inhibitors of CK1D/E
  62. 4red: Crystal Structure of Human Ampk Alpha1 Kd-aid with K43A Mutation
  63. 4rer: Crystal Structure of The Phosphorylated Human Alpha1 Beta2 Gamma1 Holo-ampk Complex Bound to Amp and Cyclodextrin
  64. 4rew: Crystal Structure of The Non-phosphorylated Human Alpha1 Beta2 Gamma1 Holo-ampk Complex
  65. 5air: Structural Analysis of Mouse GSK3BETA Fused with Lrp6 Peptide.
  66. 4ptc: Structure of a Carboxamide Compound (3) (2-{2-[(cyclopropylcarbonyl) Amino]pyridin-4-yl}-4-oxo-4h-1lambda~4~,3-thiazole-5-carboxamide) to GSK3B
  67. 4pte: Structure of a Carvoxamide Compound (15) (n-[4-(isoquinolin-7-yl) Pyridin-2-yl]cyclopropanecarboxamide) to GSK3B
  68. 4ptg: Structure of a Carboxamine Compound (26) (2-{2-[(cyclopropylcarbonyl) Amino]pyridin-4-yl}-4-methoxypyrimidine-5-carboxamide) to GSK3B
© Copyright 2008-2009 by enzymes.me.uk